Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Operating Income Loss of -$108.14 million for the year ending 2025.
- CAPRICOR THERAPEUTICS, INC. showed a decrease of -154.1% in Operating Income Loss from 2024 to 2025.
- This data is from CAPRICOR THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: -$880.2 thousand | Q3 2011: -$1.16 million | Q1 2012: -$769.9 thousand | Q2 2012: -$774.4 thousand | Q3 2012: -$576.3 thousand | Q1 2013: -$1.43 million | Q2 2013: -$1.62 million | Q3 2013: -$1.49 million | Q1 2014: -$1.19 million | Q2 2014: -$1.48 million | Q3 2014: -$1.49 million | Q1 2015: -$3.41 million | Q2 2015: -$3.06 million | Q3 2015: -$2.85 million | Q1 2016: -$4.21 million | Q2 2016: -$4.61 million | Q3 2016: -$5.24 million | Q1 2017: -$3.57 million | Q2 2017: -$3.38 million | Q3 2017: -$2.64 million | Q1 2018: -$3.69 million | Q2 2018: -$4.16 million | Q3 2018: -$4.17 million | Q1 2019: -$2.56 million | Q2 2019: -$2.07 million | Q3 2019: -$1.63 million | Q1 2020: -$2.11 million | Q2 2020: -$3.49 million | Q3 2020: -$3.91 million | Q1 2021: -$5.16 million | Q2 2021: -$5.08 million | Q3 2021: -$4.31 million | Q1 2022: -$7.83 million | Q2 2022: -$7.32 million | Q3 2022: -$6.48 million | Q1 2023: -$8.18 million | Q2 2023: -$7.75 million | Q3 2023: -$6.86 million | Q1 2024: -$10.27 million | Q2 2024: -$11.59 million | Q3 2024: -$13.01 million | Q1 2025: -$24.98 million | Q2 2025: -$27.72 million | Q3 2025: -$26.28 million.
- Over the full 16 years of available data (2010 to 2025), CAPRICOR THERAPEUTICS, INC.'s Operating Income Loss has declined by 1,618.3%.
- Historical annual values: Fiscal year 2025: -$108.14 million | Fiscal year 2024: -$42.56 million | Fiscal year 2023: -$24.08 million | Fiscal year 2022: -$29.70 million | Fiscal year 2021: -$20.94 million | Fiscal year 2020: -$13.69 million | Fiscal year 2019: -$7.73 million | Fiscal year 2018: -$15.33 million | Fiscal year 2017: -$12.86 million | Fiscal year 2016: -$16.98 million | Fiscal year 2015: -$12.61 million | Fiscal year 2014: -$6.02 million | Fiscal year 2013: -$6.90 million | Fiscal year 2012: -$2.10 million | Fiscal year 2011: -$4.90 million | Fiscal year 2010: -$6.29 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: